This is part 4 of the helpline trends report series. Read part 1, part 2, and part 3. In 2020–2021,
This is part 3 of the helpline trends report series. Read part 1, part 2, and part 4. This third
This is part 2 of the helpline trends report series. Read part 1, part 3, and part 4. This second
This is part 1 of the helpline trends report series. Read part 2, part 3, and part 4. This week,
A new RAND study found that in 2020, employers and private health insurance plans paid hospitals 224% more than Medicare
Medicare Rights recently joined over 70 organizations to launch the campaign “Push For Lower Rx Prices.” The groups are calling
Medicare provides vital health coverage, but the program’s high premiums, deductibles, and other cost-sharing requirements can put care out of
On Monday, the Centers for Medicare and Medicaid Services (CMS) announced that for the duration of the COVID-19 public health
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
This is part 4 of the helpline trends report series. Read part 1, part 2, and part 3. In 2020–2021,
This is part 3 of the helpline trends report series. Read part 1, part 2, and part 4. This third
This is part 2 of the helpline trends report series. Read part 1, part 3, and part 4. This second
This is part 1 of the helpline trends report series. Read part 2, part 3, and part 4. This week,
A new RAND study found that in 2020, employers and private health insurance plans paid hospitals 224% more than Medicare
Medicare Rights recently joined over 70 organizations to launch the campaign “Push For Lower Rx Prices.” The groups are calling
Medicare provides vital health coverage, but the program’s high premiums, deductibles, and other cost-sharing requirements can put care out of
On Monday, the Centers for Medicare and Medicaid Services (CMS) announced that for the duration of the COVID-19 public health
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
